Single application thixotropic antibiotic delivery systems for otitis externa

Information

• Research Project
• 9679139

• ApplicationId

  9679139

• Core Project Number

  R41DC017641

• Full Project Number

  1R41DC017641-01

• Serial Number

  017641

• FOA Number

  PA-18-575

• Sub Project Id

• Project Start Date

  9/1/2018 - 6 years ago

• Project End Date

  8/31/2019 - 5 years ago

• Program Officer Name

  MILLER, ROGER

• Budget Start Date

  9/1/2018 - 6 years ago

• Budget End Date

  8/31/2019 - 5 years ago

• Fiscal Year

  2018

• Support Year

  01

• Suffix

• Award Notice Date

  8/30/2018 - 6 years ago

Organizations

• PROMILIAD BIOPHARMA, INC.

The proposal seeks to initiate the development of a tetraethyl orthosilicate-based thixotropic antibiotic delivery systems for the treatment of otitis externa and prevention of malignant otitis externa. This study will set the foundation for the development of point-of-care, single application thixotropic drug delivery platform technologies for otic therapeutics.

IC Name

• Activity

  R41

• Administering IC

  DC

• Application Type

  1

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  297825

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  173

• Ed Inst. Type

• Funding ICs

  NIDCD:297825\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  PROMILIAD BIOPHARMA, INC.

• Organization Department

• Organization DUNS

  130194082

• Organization City

  ALBERTON

• Organization State

  MT

• Organization Country

  UNITED STATES

• Organization Zip Code

  598200010

• Organization District

  UNITED STATES